Lexicon Pharmaceuticals (LXRX) Gross Profit (QoQ) (2017 - 2026)
Lexicon Pharmaceuticals (LXRX) Gross Profit (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Lexicon Pharmaceuticals | 888.49 Mn | 717.83 Mn | 20.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 296.71% |
| Dec 31, 2025 | -62.66% |
| Sep 30, 2025 | -50.85% |
| Jun 30, 2025 | 2,240.34% |
| Mar 31, 2025 | -95.30% |
| Dec 31, 2024 | 1,460.81% |
| Sep 30, 2024 | 13.37% |
| Jun 30, 2024 | 39.45% |
| Mar 31, 2024 | 52.59% |
| Dec 31, 2023 | 349.03% |
| Sep 30, 2023 | -45.23% |
| Dec 31, 2020 | 131.44% |
| Sep 30, 2020 | 9.96% |
| Jun 30, 2020 | -109.46% |
| Mar 31, 2020 | -6.56% |
| Dec 31, 2019 | -97.21% |
| Sep 30, 2019 | 61,199.14% |
| Jun 30, 2019 | -124.76% |
| Mar 31, 2019 | -88.57% |
| Dec 31, 2018 | 157.24% |